Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $87.1400 (-0.51%) ($86.7300 - $88.1700) on Thu. Oct. 1, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.15% (three month average) | RSI | 38 | Latest Price | $87.1400(-0.51%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 0.3% a day on average for past five trading days. | Weekly Trend | ABBV declines -1.7% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(49%) SPLV(37%) VYM(35%) DIA(34%) IVE(33%) | Factors Impacting ABBV price | ABBV will decline at least -0.575% in a week (0% probabilities). VIXM(-25%) UUP(-9%) VXX(-6%) IGOV(-5%) EDOC(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.575% (StdDev 1.15%) | Hourly BBV | -0.6 () | Intraday Trend | -1.2% | | | |
|
1 - 5 Day Possible Target | $83.82(-3.81%) | Inflection Point | Yes | Resistance Level | $88.98 | 5 Day Moving Average | $87.03(0.13%) | 10 Day Moving Average | $87.55(-0.47%) | 20 Day Moving Average | $88.98(-2.07%) | To recent high | -13.6% | To recent low | 1.4% | Market Cap | $153.74b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |